Leber's Hereditary Optic Neuropathy with Mitochondrial DNA Mutation G11778A: A Systematic Literature Review and Meta-Analysis
- PMID: 36743514
- PMCID: PMC9893526
- DOI: 10.1155/2023/1107866
Leber's Hereditary Optic Neuropathy with Mitochondrial DNA Mutation G11778A: A Systematic Literature Review and Meta-Analysis
Abstract
Background: LHON is a progressive disease with early disease onset and male predominance, usually causing devastating visual loss to patients. These systematic review and meta-analysis are aimed at summarizing epidemiology, disease onset and progression, visual recovery, risk factors, and treatment options of Leber's hereditary optic neuropathy (LHON) with mitochondrial DNA mutation G11778A from current evidence.
Methods: The PubMed database was examined from its inception date to November 2021. Data from included studies were pooled with either a fixed-effects model or a random-effects model, depending on the results of heterogeneity tests. Sensitivity analysis was conducted to test the robustness of results.
Results: A total of 41 articles were included in the systematic review for qualitative analysis, and 34 articles were included for quantitative meta-analysis. The pooled estimate of proportion of G11778A mutation among the three primary mutations of mitochondrial DNA (G11778A, G3460A, and T14484C) for LHON was 73% (95% CI: 67% and 79%), and the LHON patients with G11778A mutation included the pooled male ratio estimate of 77% (76% and 79%), the pooled age estimate of 35.3 years (33.2 years and 37.3 years), the pooled onset age estimate of 22.1 years (19.7 years and 24.6 years), the pooled visual acuity estimate of 1.4 LogMAR (1.2 LogMAR and 1.6 LogMAR), and the pooled estimate of spontaneous visual recovery rate (in either 1 eye) of 20% (15% and 27%).
Conclusions: The G11778A mutation is a prevalent mitochondrial DNA mutation accounting for over half of LHON cases with three primary mutations. Spontaneous visual recovery is rare, and no effective treatment is currently available.
Copyright © 2023 Jiajia Yuan et al.
Conflict of interest statement
None of the authors have any conflicts of interest.
Figures









Similar articles
-
The epidemiology and mutation types of Leber's hereditary optic neuropathy in Thailand.Ann Med. 2022 Dec;54(1):1601-1607. doi: 10.1080/07853890.2022.2082517. Ann Med. 2022. PMID: 35723074 Free PMC article.
-
Leber's hereditary optic neuroretinopathy (LHON) associated with mitochondrial DNA point mutation G11778A in two Croatian families.Coll Antropol. 2006 Mar;30(1):171-4. Coll Antropol. 2006. PMID: 16617593
-
Mitochondrial variants may influence the phenotypic manifestation of Leber's hereditary optic neuropathy-associated ND4 G11778A mutation.J Genet Genomics. 2008 Nov;35(11):649-55. doi: 10.1016/S1673-8527(08)60086-7. J Genet Genomics. 2008. PMID: 19022198
-
[The influence of mitochondrial haplogroup on Leber's hereditary optic neuropathy].Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2008 Feb;25(1):45-9. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2008. PMID: 18247303 Review. Chinese.
-
Leber's hereditary optic neuropathy: a multifactorial disease.Prog Retin Eye Res. 2006 Jul;25(4):381-96. doi: 10.1016/j.preteyeres.2006.05.002. Epub 2006 Jul 7. Prog Retin Eye Res. 2006. PMID: 16829155 Review.
Cited by
-
Are Mitochondria a Potential Target for Treating β-Thalassemia?J Clin Med. 2025 Feb 8;14(4):1095. doi: 10.3390/jcm14041095. J Clin Med. 2025. PMID: 40004626 Free PMC article. Review.
-
Leber's hereditary optic neuropathy and multiple sclerosis: overlap between mitochondrial disease and neuroinflammation.Front Neurol. 2025 Feb 18;16:1538358. doi: 10.3389/fneur.2025.1538358. eCollection 2025. Front Neurol. 2025. PMID: 40040912 Free PMC article. Review.
-
Prevalence of Leber hereditary optic neuropathy in the Community of Madrid (Spain), estimation with a capture-recapture method.Orphanet J Rare Dis. 2024 May 29;19(1):220. doi: 10.1186/s13023-024-03225-7. Orphanet J Rare Dis. 2024. PMID: 38811977 Free PMC article.
-
Leber Hereditary Optic Neuropathy and Epilepsy in a Mexican Patient.Cureus. 2025 Jun 24;17(6):e86663. doi: 10.7759/cureus.86663. eCollection 2025 Jun. Cureus. 2025. PMID: 40718267 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources